Market Research Reports and Industry Reports

RNAi (adding)

  • DESCRIPTION
  • TABLE OF
    CONTENTS
  • RELATED
    REPORTS
  • SAMPLE REQUEST
  • PURCHASE BY
    SECTION

RNAi report covers the areas of Application of RNAi and the various Tools/Products in the market catering to RNAi based applications. The Application areas covered include Research, Therapeutics and Drug Development. The report provides an in depth analysis of each of the application and product areas by their respective categories. The study includes hsitoric, current and future markets for the total global RNAi market and also key regional markets, including North America, Europe, Asia-Pacific and Rest of World. Information related to recent product releases, product developments, partnerships, collaborations, mergers and acquisitions, ethical issues, regulatory affairs, and other areas of concern is also covered in the report.

1. SCOPE AND METHODOLOGY

1.1 Scope of the Study

1.2 Research Methodology

1.3 Units and Currency

2. REPORT SYNOPSIS

2.1 Introduction to RNAi

RNAi - Nature’s Way of Silencing Gene

Definition

Summary

RNAi – The Main Objectives of Our Study

RNAi – Some Basics

History of RNAi

RNAi – Origins and Discovery

2.2 Segmentation of RNAi

Exhibit 1. Segmentation of Global RNAi Market by Application and Tools/Products

Exhibit 2. Segmentation by Application

Exhibit 3. Segmentation by Tools/Products

Facts About RNAi

Relation between siRNA Length and siRNA Function

Functional Significance of siRNA Length

Is siRNA Length Influential of siRNA Function?

Use of RNAi in Mammalian Systems

2.3 RNAi - Global Market Analysis

Exhibit 4. RNAi– Global Market – Historic, Current, and Forecast (2010 -2022) in US$ Million

Exhibit 5. List of Major RNAi Global Companies

3. MARKET DYNAMICS

3.1 Global RNAi Market Overview

RNAi - A Breakthrough in Molecular Biology

Nobel Prize

RNAi – Gene Silencing Mechanism

esiRNA Technology

RNAi – The Corporate Scenario

RNAi – The Commercial Potential

RNAi – The Pharma Perspective

RNAi – Unlike Stem Cell Therapy

3.2 Global RNAi Market Analysis

Exhibit 6. RNAi – Global Market – Historic, Current, and Forecast (2010 - 2022) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million

Exhibit 7. RNAi – Global Market Shares (2012, 2018 & 2022) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World

3.3 North America RNAi Market Analysis

Exhibit 8. RNAi – North American Market – Historic, Current, and Forecast (2010 - 2022) for United States and Canada in US$ Million

Exhibit 9. RNAi – North American Market Shares (2012, 2018 & 2022) for United States and Canada

United States RNAi Market

Canadian RNAi Market

Competitor Overview

3.4 European RNAi Market Analysis

Exhibit 10. RNAi – European Market – Historic, Current, and Forecast (2010 - 2022) by Geographic Region for Germany, United Kingdom, Belgium, France, Russia and Rest of Europe in US$ Million

Exhibit 11. RNAi – EuropeanMarket Shares (2012, 2018 & 2022) by Geographic Region for Germany, United Kingdom, Belgium, France, Russia and Rest of Europe

German RNAi Market

United Kingdom RNAi Market

Belgian RNAi Market

French RNAi Market

Russian RNAi Market

Competitor Overview

3.5 Asia-Pacific RNAi Market Analysis

Exhibit 12. RNAi –Asia-Pacific Market – Historic, Current, and Forecast (2010 - 2022) by Country for Australia, Japan, China, India, South Korea and Rest of Asia-Pacific in US$ Million

Exhibit 13. RNAi – Asia-Pacific Market Shares (2012, 2018 & 2022) by Country for for Australia, Japan, China, India, South Korea and Rest of Asia-Pacific

Australian RNAi Market

Japanese RNAi Market

China RNAi Market

Indian RNAi Market

South Korean RNAi Market

Competitor Overview

3.6 Rest of World RNAi Market Analysis

Exhibit 14. RNAi – Rest of World Market – Historic, Current, and Forecast (2010 - 2022) for Brazil, Israel, South Africa and Other Countries in US$ Million

Exhibit 15. RNAi – Rest of World Market Shares (2012, 2018 & 2022) for Brazil, Israel, South Africa and Other Countries in US$ Million

Brazilian RNAi Market

Israeli RNAi Market

South African RNAi Market

Competitor Overview

3.7 RNAi - Market Trends

RNAi – An Emerging Class of Drugs in Pharmaceuticals

Biotech/Pharma Industry’s Interest in RNAi

RNAi’s Functionality

Sourcing and Market Potential

Marketing Strategy

Economic Possibilities

Mission Ahead for RNAi

Biotech Companies Realize to Gain Billions of Dollars by Applying RNAi Technology

RNAi - Focus on Modeling Cellular Systems

Initial Stages of Mammalian RNAi Screening

Development of Signaling Pathways Using a Mammalian RNAi Screen

Identification of Components in a Biological Process: RNA interference

Component Discovery

Reporter Assays and High-Content Image-based Screening

Component Validation and Classification

An Outlook on Binary Genetic Interactions with RNAi

Hypothetical RNAi Screening for Cell-Growth Regulators

Prospects of Knockdown Technology

RNA interference (RNAi)

Introduction

Redefinition of RNA

Knockdown of Genes

RNAi on a Large Scale

RNAi: Beyond Machinery

Silencing Diseases

Principle Behind RNAi

Delivery

Area of Concern

3.8 Analysis by Application

Exhibit 16. RNAi Applications – Global Market – Historic, Current, and Forecast (2010 -2022) by Type for Research, Therapeutics, Drug Development and Other in US$ Million

Exhibit 17. RNAi Applications - Global Market Shares (2012, 2018 & 2022) by Type for Research, Therapeutics, Drug Development and Other

3.8.1.1 Global Market for RNAi in Research

Exhibit 18. RNAi in Research - Global Market – Historic, Current, and Forecast (2010 - 2022) by Application for Functional Genomics, Protein Chemistry, Metabolism and Other in US$ Million

Exhibit 19. RNAi in Research - Global Market Shares (2012, 2018 & 2022) by Application for Functional Genomics, Protein Chemistry, Metabolism and Other

Exhibit 20. RNAi in Research - Global Market – Historic, Current, and Forecast (2010 - 2022) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million

Exhibit 21. RNAi in Research - Global Market Shares (2012, 2018 & 2022) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World

3.8.1.2 North American Market for RNAi in Research

Exhibit 22. RNAi in Research – North American Market – Historic, Current, and Forecast (2010 - 2022) for United States and Canada in US$ Million

Exhibit 23. RNAi in Research – North American Market Shares (2012, 2018 & 2022) for United States and Canada

3.8.1.3 European Market for RNAi in Research

Exhibit 24. RNAi in Research - European Market – Historic, Current, and Forecast (2010 – 2022) by Country for Germany, United Kingdom, Belgium, France, Russia and Rest of Europe in US$ Million

Exhibit 25. RNAi in Research - European Market Shares (2012, 2018 & 2022) by Country for Germany, United Kingdom, Belgium, France, Russia and Rest of Europe

3.8.1.4 Asia-Pacific Market for RNAi in Research

Exhibit 26. RNAi in Research - Asia-Pacific Market – Historic, Current, and Forecast (2010 - 2022) by Country for Australia, Japan, China, India, South Korea and Rest of Asia-Pacific in US$ Million

Exhibit 27. RNAi in Research – Asia-Pacific Market Shares (2012, 2018 & 2022) by Country for Australia, Japan, China, India, South Korea and Rest of Asia-Pacific

3.8.1.5 Rest of World Market for RNAi in Research

Exhibit 28. RNAi in Research – Rest of World Market – Historic, Current, and Forecast (2010 - 2022) for Brazil, Israel, South Africa and Other Countries US$ Million

Exhibit 29. RNAi in Research – Rest of World Market Shares (2012, 2018 & 2022) for Brazil, Israel, South Africa and Other Countries US$ Million

3.8.1.(a) RNAi in Functional Genomics

3.8.1.(a).1 Global Market for RNAi in Functional Genomics

Exhibit 30. RNAi in Functional Genomics – Global Market – Historic, Current, and Forecast (2010 - 2022) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million

Exhibit 31. RNAi in Functional Genomics – Global Market Shares (2012, 2018 & 2022) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World

3.8.1.(a).2 North American Market for RNAi in Functional Genomics

Exhibit 32. RNAi in Functional Genomics – North American Market – Historic, Current, and Forecast (2010 - 2022) for United States and Canada in US$ Million

Exhibit 33. RNAi in Functional Genomics – North American Market Shares (2012, 2018 & 2022) for United States and Canada

3.8.1.(a).3 European Market for RNAi in Functional Genomics

Exhibit 34. RNAi in Functional Genomics- European Market – Historic, Current, and Forecast (2010 - 2022)by Country for Germany, United Kingdom, Belgium, France, Russia and Rest of Europe in US$ Million

Exhibit 35. RNAi in Functional Genomics - European Market Shares (2012, 2018 & 2022) by Country for Germany, United Kingdom, Belgium, France, Russia and Rest of Europe

3.8.1.(a).4 Asia-Pacific Market for RNAi in Functional Genomics

Exhibit 36. RNAi in Functional Genomics- Asia-Pacific Market – Historic, Current, and Forecast (2010 - 2022) by Country for Australia, Japan, China, India, South Korea and Rest of Asia-Pacific in US$ Million

Exhibit 37. RNAi in Functional Genomics – Asia-Pacific Market Shares (2012, 2018 & 2022) by Country for Australia, Japan, China, India, South Korea and Rest of Asia-Pacific

3.8.1.(a).5 Rest of World Market for RNAi in Functional Genomics

Exhibit 38. RNAi in Functional Genomics – Rest of World Market – Historic, Current, and Forecast (2010 - 2022) for Brazil, Israel, South Africa and Other Countries US$ Million

Exhibit 39. RNAi in Functional Genomics – Rest of World Market Shares (2012, 2018 & 2022) for Brazil, Israel, South Africa and Other Countries US$ Million

3.8.1.(b) RNAi in Protein Chemistry

3.8.1.(b).1 Global Market for RNAi in Protein Chemistry

Exhibit 40. RNAi in Protein Chemistry– Global Market – Historic, Current, and Forecast (2010 - 2022) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million

Exhibit 41. RNAi in Protein Chemistry – Global Market Shares (2012, 2018 & 2022) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World

3.8.1.(b).2 North American Market for RNAi in Protein Chemistry

Exhibit 42. RNAi in Protein Chemistry – North American Market – Historic, Current, and Forecast (2010 - 2022) for United States and Canada in US$ Million

Exhibit 43. RNAi in Protein Chemistry – North American Market Shares (2012, 2018 & 2022) for United States and Canada

3.8.1.(b).3 European Market for RNAi in Protein Chemistry

Exhibit 44. RNAi in Protein Chemistry - European Market – Historic, Current, and Forecast (2010 - 2022)by Country for Germany, United Kingdom, Belgium, France, Russia and Rest of Europe in US$ Million

Exhibit 45. RNAi in Protein Chemistry - European Market Shares (2012, 2018 & 2022) by Country for Germany, United Kingdom, Belgium, France, Russia and Rest of Europe

3.8.1.(b).4 Asia-Pacific Market for RNAi in Protein Chemistry

Exhibit 46. RNAi in Protein Chemistry- Asia-Pacific Market – Historic, Current, and Forecast (2010 - 2022) by Country for Australia, Japan, China, India, South Korea and Rest of Asia-Pacific in US$ Million

Exhibit 47. RNAi in Protein Chemistry – Asia-Pacific Market Shares (2012, 2018 & 2022) by Country for Australia, Japan, China, India, South Korea and Rest of Asia-Pacific

3.8.1.(b).5 Rest of World Market for RNAi in Protein Chemistry

Exhibit 48. RNAi in Protein Chemistry – Rest of World Market – Historic, Current, and Forecast (2010 - 2022) for Brazil, Israel, South Africa and Other Countries US$ Million

Exhibit 49. RNAi in Protein Chemistry – Rest of World Market Shares (2012, 2018 & 2022) for Brazil, Israel, South Africa and Other Countries US$ Million

3.8.1.(c) RNAi in Metabolism

3.8.1.(c).1 Global Market for RNAi in Metabolism

Exhibit 50. RNAi in Metabolism– Global Market – Historic, Current, and Forecast (2010 - 2022) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million

Exhibit 51. RNAi in Metabolism – Global Market Shares (2012, 2018 & 2022) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World

3.8.1.(c).2 North American Market for RNAi in Metabolism

Exhibit 52. RNAi in Metabolism – North American Market – Historic, Current, and Forecast (2010 - 2022) for United States and Canada in US$ Million

Exhibit 53. RNAi in Metabolism – North American Market Shares (2012, 2018 & 2022) for United States and Canada

3.8.1.(c).3 European Market for RNAi in Metabolism

Exhibit 54. RNAi in Metabolism - European Market – Historic, Current, and Forecast (2010 - 2022)by Country for Germany, United Kingdom, Belgium, France, Russia and Rest of Europe in US$ Million

Exhibit 55. RNAi in Metabolism - European Market Shares (2012, 2018 & 2022) by Country for Germany, United Kingdom, Belgium, France, Russia and Rest of Europe

3.8.1.(c).4 Asia-Pacific Market for RNAi in Metabolism

Exhibit 56. RNAi in Metabolism- Asia-Pacific Market – Historic, Current, and Forecast (2010 - 2022) by Country for Australia, Japan, China, India, South Korea and Rest of Asia-Pacific in US$ Million

Exhibit 57. RNAi in Metabolism – Asia-Pacific Market Shares (2012, 2018 & 2022) by Country for Australia, Japan, China, India, South Korea and Rest of Asia-Pacific

3.8.1.(c).5 Rest of World Market for RNAi in Metabolism

Exhibit 58. RNAi in Metabolism – Rest of World Market – Historic, Current, and Forecast (2010 - 2022) for Brazil, Israel, South Africa and Other Countries US$ Million

Exhibit 59. RNAi in Metabolism – Rest of World Market Shares (2012, 2018 & 2022) for Brazil, Israel, South Africa and Other Countries US$ Million

3.8.1.(d) RNAi in Other Research Applications

3.8.1.(d).1 Global Market for RNAi in Other Research Applications

Exhibit 60. RNAi in Other Research Applications – Global Market – Historic, Current, and Forecast (2010 - 2022) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million

Exhibit 61. RNAi in Other Research Applications – Global Market Shares (2012, 2018 & 2022) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World

3.8.1.(d).2 North American Market for RNAi in Other Research Applications

Exhibit 62. RNAi in Other Research Applications – North American Market – Historic, Current, and Forecast (2010 - 2022) for United States and Canada in US$ Million

Exhibit 63. RNAi in Other Research Applications – North American Market Shares (2012, 2018 & 2022) for United States and Canada

3.8.1.(d).3 European Market for RNAi in Other Research Applications

Exhibit 64. RNAi in Other Research Applications - European Market – Historic, Current, and Forecast (2010 - 2022)by Country for Germany, United Kingdom, Belgium, France, Russia and Rest of Europe in US$ Million

Exhibit 65. RNAi in Other Research Applications - European Market Shares (2012, 2018 & 2022) by Country for Germany, United Kingdom, Belgium, France, Russia and Rest of Europe

3.8.1.(d).4 Asia-Pacific Market for RNAi in Other Research Applications

Exhibit 66. RNAi in Other Research Applications- Asia-Pacific Market – Historic, Current, and Forecast (2010 - 2022) by Country for Australia, Japan, China, India, South Korea and Rest of Asia-Pacific in US$ Million

Exhibit 67. RNAi in Other Research Applications – Asia-Pacific Market Shares (2012, 2018 & 2022) by Country for Australia, Japan, China, India, South Korea and Rest of Asia-Pacific

3.8.1.(d).5 Rest of World Market for RNAi in Other Research Applications

Exhibit 68. RNAi in Other Research Applications – Rest of World Market – Historic, Current, and Forecast (2010 - 2022) for Brazil, Israel, South Africa and Other Countries US$ Million

Exhibit 69. RNAi in Other Research Applications – Rest of World Market Shares (2012, 2018 & 2022) for Brazil, Israel, South Africa and Other Countries US$ Million

3.8.2 RNAi Therapeutics

Exhibit 70. RNAi Therapeutics - Global Market – Historic, Current, and Forecast (2010 - 2022) by Application for Ophthalmology, Virology, Neurology, Oncology and Other in US$ Million

Exhibit 71. RNAi Therapeutics - Global Market Shares (2012, 2018 & 2022) by Application for Ophthalmology, Virology, Neurology, Oncology and Other

Exhibit 72. Drug Development Status of RNAi based Therapeutics

3.8.2.1 Global Market for RNAi Therapeutics

Exhibit 73. RNAi Therapeutics - Global Market – Historic, Current, and Forecast (2010 - 2022) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million

Exhibit 74. RNAi Therapeutics - Global Market Shares (2012, 2018 & 2022) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World

3.8.2.2 North American Market for RNAi Therapeutics

Exhibit 75. RNAi Therapeutics – North American Market – Historic, Current, and Forecast (2010 - 2022) for United States and Canada in US$ Million

Exhibit 76. RNAi Therapeutics – North American Market Shares (2012, 2018 & 2022) for United States and Canada

3.8.2.3 European Market for RNAi Therapeutics

Exhibit 77. RNAi Therapeutics -European Market – Historic, Current, and Forecast (2010 - 2022) by Country for Germany, United Kingdom, Belgium, France, Russia and Rest of Europe in US$ Million

Exhibit 78. RNAi Therapeutics – European Market Shares (2012, 2018 & 2022) by Country for Germany, United Kingdom, Belgium, France, Russia and Rest of Europe

3.8.2.4 Asia-Pacific Market for RNAi Therapeutics

Exhibit 79. RNAi Therapeutics - Asia-Pacific Market – Historic, Current, and Forecast (2010 - 2022) by Country for Australia, Japan, China, India, South Korea and Rest of Asia-Pacific in US$ Million

Exhibit 80. RNAi Therapeutics – Asia-Pacific Market Shares (2012, 2018 & 2022) by Country for Australia, Japan, China, India, South Korea and Rest of Asia-Pacific

3.8.2.5 Rest of World Market for RNAi Therapeutics

Exhibit 81. RNAi Therapeutics – Rest of World Market – Historic, Current, and Forecast (2010 - 2022) for Brazil, Israel, South Africa and Other Countries US$ Million

Exhibit 82. RNAi Therapeutics – Rest of World Market Shares (2012, 2018 & 2022) for Brazil, Israel, South Africa and Other Countries US$ Million

3.8.2.(a) RNAi in Ophthalmology

3.8.2.(a).1 Global Market for RNAi in Ophthalmology

Exhibit 83. RNAi in Ophthalmology - Global Market – Historic, Current, and Forecast (2010 - 2022) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million

Exhibit 84. RNAi in Ophthalmology - Global Market Shares (2012, 2018 & 2022) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World

3.8.2.(a).2 North American Market for RNAi in Ophthalmology

Exhibit 85. RNAi in Ophthalmology – North American Market – Historic, Current, and Forecast (2010 - 2022) for United States and Canada in US$ Million

Exhibit 86. RNAi in Ophthalmology – North American Market Shares (2012, 2018 & 2022) for United States and Canada

3.8.2.(a).3 European Market for RNAi in Ophthalmology

Exhibit 87. RNAi in Ophthalmology - European Market – Historic, Current, and Forecast (2010 - 2022) by Country for Germany, United Kingdom, Belgium, France, Russia and Rest of Europe in US$ Million

Exhibit 88. RNAi in Ophthalmology – European Market Shares (2012, 2018 & 2022) by Country for Germany, United Kingdom, Belgium, France, Russia and Rest of Europe

3.8.2.(a).4 Asia-Pacific Market for RNAi in Ophthalmology

Exhibit 89. RNAi in Ophthalmology - Asia-Pacific Market – Historic, Current, and Forecast (2010 - 2022) by Country for Australia, Japan, China, India, South Korea and Rest of Asia-Pacific in US$ Million

Exhibit 90. RNAi in Ophthalmology – Asia-Pacific Market Shares (2012, 2018 & 2022) by Country for Australia, Japan, China, India, South Korea and Rest of Asia-Pacific

3.8.2.(a).5 Rest of World Market for RNAi in Ophthalmology

Exhibit 91. RNAi in Ophthalmology – Rest of World Market – Historic, Current, and Forecast (2010 - 2022) for Brazil, Israel, South Africa and Other Countries US$ Million

Exhibit 92. RNAi in Ophthalmology – Rest of World Market Shares (2012, 2018 & 2022) for Brazil, Israel, South Africa and Other Countries US$ Million

3.8.2.(b) RNAi in Virology

3.8.2.(b).1 Global Market for RNAi in Virology

Exhibit 93. RNAi in Virology - Global Market – Historic, Current, and Forecast (2010 - 2022) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million

Exhibit 94. RNAi in Virology - Global Market Shares (2012, 2018 & 2022) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World

3.8.2.(b).2 North American Market for RNAi in Virology

Exhibit 95. RNAi in Virology – North American Market – Historic, Current, and Forecast (2010 - 2022) for United States and Canada in US$ Million

Exhibit 96. RNAi in Virology – North American Market Shares (2012, 2018 & 2022) for United States and Canada

3.8.2.(b).3 European Market for RNAi in Virology

Exhibit 97. RNAi in Virology - European Market – Historic, Current, and Forecast (2010 - 2022) by Country for Germany, United Kingdom, Belgium, France, Russia and Rest of Europe in US$ Million

Exhibit 98. RNAi in Virology – European Market Shares (2012, 2018 & 2022) by Country for Germany, United Kingdom, Belgium, France, Russia and Rest of Europe

3.8.2.(b).4 Asia-Pacific Market for RNAi in Virology

Exhibit 99. RNAi in Virology - Asia-Pacific Market – Historic, Current, and Forecast (2010 - 2022) by Country for Australia, Japan, China, India, South Korea and Rest of Asia-Pacific in US$ Million

Exhibit 100. RNAi in Virology – Asia-Pacific Market Shares (2012, 2018 & 2022) by Country for Australia, Japan, China, India, South Korea and Rest of Asia-Pacific

3.8.2.(b).5 Rest of World Market for RNAi in Virology

Exhibit 101. RNAi in Virology – Rest of World Market – Historic, Current, and Forecast (2010 - 2022) for Brazil, Israel, South Africa and Other Countries US$ Million

Exhibit 102. RNAi in Virology – Rest of World Market Shares (2012, 2018 & 2022) for Brazil, Israel, South Africa and Other Countries US$ Million

3.8.2.(c) RNAi in Neurology

3.8.2.(c).1 Global Market for RNAi in Neurology

Exhibit 103. RNAi in Neurology - Global Market – Historic, Current, and Forecast (2010 - 2022) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million

Exhibit 104. RNAi in Neurology - Global Market Shares (2012, 2018 & 2022) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World

3.8.2.(c).2 North American Market for RNAi in Neurology

Exhibit 105. RNAi in Neurology – North American Market – Historic, Current, and Forecast (2010 - 2022) for United States and Canada in US$ Million

Exhibit 106. RNAi in Neurology – North American Market Shares (2012, 2018 & 2022) for United States and Canada

3.8.2.(c).3 European Market for RNAi in Neurology

Exhibit 107. RNAi in Neurology -European Market – Historic, Current, and Forecast (2010 - 2022) by Country for Germany, United Kingdom, Belgium, France, Russia and Rest of Europe in US$ Million

Exhibit 108. RNAi in Neurology – European Market Shares (2012, 2018 & 2022) by Country for Germany, United Kingdom, Belgium, France, Russia and Rest of Europe

3.8.2.(c).4 Asia-Pacific Market for RNAi in Neurology

Exhibit 109. RNAi in Neurology - Asia-Pacific Market – Historic, Current, and Forecast (2010 - 2022) by Country for Australia, Japan, China, India, South Korea and Rest of Asia-Pacific in US$ Million

Exhibit 110. RNAi in Neurology – Asia-Pacific Market Shares (2012, 2018 & 2022) by Country for Australia, Japan, China, India, South Korea and Rest of Asia-Pacific

3.8.2.(c).5 Rest of World Market for RNAi in Neurology

Exhibit 111. RNAi in Neurology – Rest of World Market – Historic, Current, and Forecast (2010 - 2022) for Brazil, Israel, South Africa and Other Countries US$ Million

Exhibit 112. RNAi in Neurology – Rest of World Market Shares (2012, 2018 & 2022) for Brazil, Israel, South Africa and Other Countries US$ Million

3.8.2.(d) RNAi in Oncology

3.8.2.(d).1 Global Market for RNAi in Oncology

Exhibit 113. RNAi in Oncology - Global Market – Historic, Current, and Forecast (2010 - 2022) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million

Exhibit 114. RNAi in Oncology - Global Market Shares (2012, 2018 & 2022) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World

3.8.2.(d).2 North American Market for RNAi in Oncology

Exhibit 115. RNAi in Oncology – North American Market – Historic, Current, and Forecast (2010 - 2022) for United States and Canada in US$ Million

Exhibit 116. RNAi in Oncology – North American Market Shares (2012, 2018 & 2022) for United States and Canada

3.8.2.(d).3 European Market for RNAi in Oncology

Exhibit 117. RNAi in Oncology - European Market – Historic, Current, and Forecast (2010 - 2022) by Country for Germany, United Kingdom, Belgium, France, Russia and Rest of Europe in US$ Million

Exhibit 118. RNAi in Oncology – European Market Shares (2012, 2018 & 2022) by Country for Germany, United Kingdom, Belgium, France, Russia and Rest of Europe

3.8.2.(d).4 Asia-Pacific Market for RNAi in Oncology

Exhibit 119. RNAi in Oncology - Asia-Pacific Market – Historic, Current, and Forecast (2010 - 2022) by Country for Australia, Japan, China, India, South Korea and Rest of Asia-Pacific in US$ Million

Exhibit 120. RNAi in Oncology – Asia-Pacific Market Shares (2012, 2018 & 2022) by Country for Australia, Japan, China, India, South Korea and Rest of Asia-Pacific

3.8.2.(d).5 Rest of World Market for RNAi in Oncology

Exhibit 121. RNAi in Oncology – Rest of World Market – Historic, Current, and Forecast (2010 - 2022) for Brazil, Israel, South Africa and Other Countries US$ Million

Exhibit 122. RNAi in Oncology – Rest of World Market Shares (2012, 2018 & 2022) for Brazil, Israel, South Africa and Other Countries US$ Million

3.8.2.(e) Other RNAi Therapeutics

3.8.2.(e).1 Global Market for Other RNAi Therapeutics

Exhibit 123. Other RNAi Therapeutics - Global Market – Historic, Current, and Forecast (2010 - 2022) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million

Exhibit 124. Other RNAi Therapeutics - Global Market Shares (2012, 2018 & 2022) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World

3.8.2.(e).2 North American Market for Other RNAi Therapeutics

Exhibit 125. Other RNAi Therapeutics – North American Market – Historic, Current, and Forecast (2010 - 2022) for United States and Canada in US$ Million

Exhibit 126. Other RNAi Therapeutics – North American Market Shares (2012, 2018 & 2022) for United States and Canada

3.8.2.(e).3 European Market for Other RNAi Therapeutics

Exhibit 127. Other RNAi Therapeutics - European Market – Historic, Current, and Forecast (2010 - 2022) by Country for Germany, United Kingdom, Belgium, France, Russia and Rest of Europe in US$ Million

Exhibit 128. Other RNAi Therapeutics – European Market Shares (2012, 2018 & 2022) by Country for Germany, United Kingdom, Belgium, France, Russia and Rest of Europe

3.8.2.(e).4 Asia-Pacific Market for Other RNAi Therapeutics

Exhibit 129. Other RNAi Therapeutics - Asia-Pacific Market – Historic, Current, and Forecast (2010 - 2022) by Country for Australia, Japan, China, India, South Korea and Rest of Asia-Pacific in US$ Million

Exhibit 130. Other RNAi Therapeutics – Asia-Pacific Market Shares (2012, 2018 & 2022) by Country for Australia, Japan, China, India, South Korea and Rest of Asia-Pacific

3.8.2.(e).5 Rest of World Market for Other RNAi Therapeutics

Exhibit 131. Other RNAi Therapeutics – Rest of World Market – Historic, Current, and Forecast (2010 - 2022) for Brazil, Israel, South Africa and Other Countries US$ Million

Exhibit 132. Other RNAi Therapeutics – Rest of World Market Shares (2012, 2018 & 2022) for Brazil, Israel, South Africa and Other Countries US$ Million

3.8.3 RNAi in Drug Development

Exhibit 133. RNAi in Drug Development - Global Market – Historic, Current, and Forecast (2010 - 2022) by Application for Target Validation, Target Identification, Drug Mechanism and Other in US$ Million

Exhibit 134. RNAi in Drug Development - Global Market Shares (2012, 2018 & 2022) by Application for Target Validation, Target Identification, Drug Mechanism and Other

3.8.3.1 Global Market for RNAi in Drug Development

Exhibit 135. RNAi in Drug Development - Global Market – Historic, Current, and Forecast (2010 - 2022) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million

Exhibit 136. RNAi in Drug Development - Global Market Shares (2012, 2018 & 2022) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World

3.8.3.2 North American Market for RNAi in Drug Development

Exhibit 137. RNAi in Drug Development – North American Market – Historic, Current, and Forecast (2010 - 2022) for United States and Canada in US$ Million

Exhibit 138. RNAi in Drug Development – North American Market Shares (2012, 2018 & 2022) for United States and Canada

3.8.3.3 European Market for RNAi in Drug Development

Exhibit 139. RNAi in Drug Development - European Market – Historic, Current, and Forecast (2010 - 2022) by Country for Germany, United Kingdom, Belgium, France, Russia and Rest of Europe in US$ Million

Exhibit 140. RNAi in Drug Development– European Market Shares (2012, 2018 & 2022) by Country for Germany, United Kingdom, Belgium, France, Russia and Rest of Europe

3.8.3.4 Asia-Pacific Market for RNAi in Drug Development

Exhibit 141. RNAi in Drug Development - Asia-Pacific Market – Historic, Current, and Forecast (2010 - 2022) by Country for Australia, Japan, China, India, South Korea and Rest of Asia-Pacific in US$ Million

Exhibit 142. RNAi in Drug Development– Asia-Pacific Market Shares (2012, 2018 & 2022) by Country for Australia, Japan, China, India, South Korea and Rest of Asia-Pacific

3.8.3.5 Rest of World Market for RNAi in Drug Development

Exhibit 143. RNAi in Drug Development – Rest of Wolrd Market – Historic, Current, and Forecast (2010 - 2022) by Country for Brazil , Israel, South Africa and Other Countries in US$ Million

Exhibit 144. RNAi in Drug Development – Rest of Wolrd Market Shares (2012, 2018 & 2022) by Country for Brazil , Israel, South Africa and Other Countries in US$ Million

3.8.3.(a) RNAi in Target Validation

3.8.3.(a).1 Global Market for RNAi in Target Validation

Exhibit 145. RNAi in Target Validation - Global Market – Historic, Current, and Forecast (2010 - 2022) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million

Exhibit 146. RNAi in Target Validation - Global Market Shares (2012, 2018 & 2022) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World

3.8.3.(a).2 North American Market for RNAi in Target Validation

Exhibit 147. RNAi in Target Validation – North American Market – Historic, Current, and Forecast (2010 - 2022) for United States and Canada in US$ Million

Exhibit 148. RNAi in Target Validation – North American Market Shares (2012, 2018 & 2022) for United States and Canada

3.8.3.(a).2 European Market for RNAi in Target Validation

Exhibit 149. RNAi in Target Validation - European Market – Historic, Current, and Forecast (2010 - 2022) by Country for Germany, United Kingdom, Belgium, France, Russia and Rest of Europe in US$ Million

Exhibit 150. RNAi in Target Validation– European Market Shares (2012, 2018 & 2022) by Country for Germany, United Kingdom, Belgium, France, Russia and Rest of Europe

3.8.3.(a).3 Asia-Pacific Market for RNAi in Target Validation

Exhibit 151. RNAi in Target Validation - Asia-Pacific Market – Historic, Current, and Forecast (2010 - 2022) by Country for Australia, Japan, China, India, South Korea and Rest of Asia-Pacific in US$ Million

Exhibit 152. RNAi in Target Validation– Asia-Pacific Market Shares (2012, 2018 & 2022) by Country for Australia, Japan, China, India, South Korea and Rest of Asia-Pacific

3.8.3.(a).4 Rest of World Market for RNAi in Target Validation

Exhibit 153. RNAi in Target Validation – Rest of World Market – Historic, Current, and Forecast (2010 - 2022) for Brazil, Israel, South Africa and Other Countries in US$ Million

Exhibit 154. RNAi in Target Validation – Rest of World Market Shares (2012, 2018 & 2022) for Brazil, Israel, South Africa and Other Countries

3.8.3.(b) RNAi in Target Identification

3.8.3.(b).1 Global Market for RNAi in Target Identification

Exhibit 155. RNAi in Target Identification - Global Market – Historic, Current, and Forecast (2010 - 2022) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million

Exhibit 156. RNAi in Target Identification - Global Market Shares (2012, 2018 & 2022) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World

3.8.3.(b).2 North American Market for RNAi in Target Identification

Exhibit 157. RNAi in Target Identification – North American Market – Historic, Current, and Forecast (2010 - 2022) for United States and Canada in US$ Million

Exhibit 158. RNAi in Target Identification – North American Market Shares (2012, 2018 & 2022) for United States and Canada

3.8.3.(b).3 European Market for RNAi in Target Identification

Exhibit 159. RNAi in Target Identification - European Market – Historic, Current, and Forecast (2010 - 2022) by Country for Germany, United Kingdom, Belgium, France, Russia and Rest of Europe in US$ Million

Exhibit 160. RNAi in Target Identification– European Market Shares (2012, 2018 & 2022) by Country for Germany, United Kingdom, Belgium, France, Russia and Rest of Europe

3.8.3.(b).4 Asia-Pacific Market for RNAi in Target Identification

Exhibit 161. RNAi in Target Identification - Asia-Pacific Market – Historic, Current, and Forecast (2010 - 2022) by Country for Australia, Japan, China, India, South Korea and Rest of Asia-Pacific in US$ Million

Exhibit 162. RNAi in Target Identification– Asia-Pacific Market Shares (2012, 2018 & 2022) by Country for Australia, Japan, China, India, South Korea and Rest of Asia-Pacific

3.8.3.(b).5 Rest of World Market for RNAi in Target Identification

Exhibit 163. RNAi in Target Identification – Rest of World Market – Historic, Current, and Forecast (2010 - 2022) for Brazil, Israel, South Africa and Other Countries US$ Million

Exhibit 164. RNAi in Target Identification – Rest of World Market Shares (2012, 2018 & 2022) for Brazil, Israel, South Africa and Other Countries US$ Million

3.8.3.(c) RNAi in Drug Mechanism

3.8.3.(c).1 Global Market for RNAi in Drug Mechanism

Exhibit 165. RNAi in Drug Mechanism - Global Market – Historic, Current, and Forecast (2010 - 2022) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million

Exhibit 166. RNAi in Drug Mechanism - Global Market Shares (2012, 2018 & 2022) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World

3.8.3.(c).2 North American Market for RNAi in Drug Mechanism

Exhibit 167. RNAi in Drug Metabolism – North American Market – Historic, Current, and Forecast (2010 - 2022) for United States and Canada in US$ Million

Exhibit 168. RNAi in Drug Metabolism – North American Market Shares (2012, 2018 & 2022) for United States and Canada

3.8.3.(c).3 European Market for RNAi in Drug Mechanism

Exhibit 169. RNAi in Drug Mechanism - European Market – Historic, Current, and Forecast (2010 - 2022) by Country for Germany, United Kingdom, Belgium, France, Russia and Rest of Europe in US$ Million

Exhibit 170. RNAi in Drug Mechanism– European Market Shares (2012, 2018 & 2022) by Country for Germany, United Kingdom, Belgium, France, Russia and Rest of Europe

3.8.3.(c).4 Asia-Pacific Market for RNAi in Drug Mechanism

Exhibit 171. RNAi in Drug Mechanism - Asia-Pacific Market – Historic, Current, and Forecast (2010 - 2022) by Country for Australia, Japan, China, India, South Korea and Rest of Asia-Pacific in US$ Million

Exhibit 172. RNAi in Drug Mechanism– Asia-Pacific Market Shares (2012, 2018 & 2022) by Country for Australia, Japan, China, India, South Korea and Rest of Asia-Pacific

3.8.3.(c).5 Rest of World Market for RNAi in Drug Mechanism

Exhibit 173. RNAi in Drug Metabolism – Rest of World Market – Historic, Current, and Forecast (2010 - 2022) for Brazil, Israel, South Africa and Other Countries US$ Million

Exhibit 174. RNAi in Drug Metabolism – Rest of World Market Shares (2012, 2018 & 2022) for Brazil, Israel, South Africa and Other Countries US$ Million

3.8.3.(d) RNAi in Other Drug Development Applications

3.8.3.(d).1 Global Market for RNAi in Other Drug Development Applications

Exhibit 175. RNAi in Other Drug Development Applications - Global Market – Historic, Current, and Forecast (2010 - 2022) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million

Exhibit 176. RNAi in Other Drug Development Applications - Global Market Shares (2012, 2018 & 2022) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World

3.8.3.(d).2 North American Market for RNAi in Other Drug Development Applications

Exhibit 177. RNAi in Other Drug Development Applications – North American Market – Historic, Current, and Forecast (2010 - 2022) for United States and Canada in US$ Million

Exhibit 178. RNAi in Other Drug Development Applications – North American Market Shares (2012, 2018 & 2022) for United States and Canada

3.8.3.(d).3 European Market for RNAi in Other Drug Development Applications

Exhibit 179. RNAi in Other Drug Development Applications - European Market – Historic, Current, and Forecast (2010 - 2022) by Country for Germany, United Kingdom, Belgium, France, Russia and Rest of Europe in US$ Million

Exhibit 180. RNAi in Other Drug Development Applications– European Market Shares (2012, 2018 & 2022) by Country for Germany, United Kingdom, Belgium, France, Russia and Rest of Europe

3.8.3.(d).4 Asia-Pacific Market for RNAi in Other Drug Development Applications

Exhibit 181. RNAi in Other Drug Development Applications - Asia-Pacific Market – Historic, Current, and Forecast (2010 - 2022) by Country for Australia, Japan, China, India, South Korea and Rest of Asia-Pacific in US$ Million

Exhibit 182. RNAi in Other Drug Development Applications– Asia-Pacific Market Shares (2012, 2018 & 2022) by Country for Australia, Japan, China, India, South Korea and Rest of Asia-Pacific

3.8.3.(d).5 Rest of World Market for RNAi in Other Drug Development Applications

Exhibit 183. RNAi in Other Drug Development Applications – Rest of World Market – Historic, Current, and Forecast (2010 - 2022) for Brazil, Israel, South Africa and Other Countries US$ Million

Exhibit 184. RNAi in Other Drug Development Applications – Rest of World Market Shares (2012, 2018 & 2022) for Brazil, Israel, South Africa and Other Countries US$ Million

3.9 Analysis by Tools/Products

Exhibit 185. RNAi Tools/Products – Global Market – Historic, Current, and Forecast (2010 - 2022) by Type for Design/Software, Synthesis, Delivery, Monitoring/Optimizing, Libraries and Other in US$ Million

Exhibit 186. RNAi Tools/Products – Global Market Shares (2012, 2018 & 2022) by Type for Design/Software, Synthesis, Delivery, Monitoring/Optimizing, Libraries and Other

3.9.1 RNAi Design/Software Market

Exhibit 187. RNAi Design/Software Tools/Products - Global Market – Historic, Current, and Forecast (2010 - 2022) by Type for MiRNA Target Scan, MiRNA Analysis Software, Design Algorithm and Other in US$ Million

Exhibit 188. RNAi Design/Software Tools/Products - Global Market Shares (2012, 2018 & 2022) by Type for MiRNA Target Scan, MiRNA Analysis Software, Design Algorithm and Other

3.9.1.1 Global RNAi Design/Software Market

Exhibit 189. RNAi Design/Software - Global Market – Historic, Current, and Forecast (2010 - 2022) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million

Exhibit 190. RNAi Design/Software - Global Market Shares (2012, 2018 & 2022) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World

3.9.1.2 North American RNAi Design/Software Market

Exhibit 191. RNAi Design/Software – North American Market – Historic, Current, and Forecast (2010 - 2022) for United States and Canada in US$ Million

Exhibit 192. RNAi Design/Software – North American Market Shares (2012, 2018 & 2022) for United States and Canada

3.9.1.3 European RNAi Design/Software Market

Exhibit 193. RNAi Design/Software - European Market – Historic, Current, and Forecast (2010 - 2022) by Country for Germany, United Kingdom, Belgium, France, Russia and Rest of Europe in US$ Million

Exhibit 194. RNAi Design/Software – European Market Shares (2012, 2018 & 2022) by Country for Germany, United Kingdom, Belgium, France, Russia and Rest of Europe

3.9.1.4 Asia-Pacific RNAi Design/Software Market

Exhibit 195. RNAi Design/Software - Asia-Pacific Market – Historic, Current, and Forecast (2010 - 2022) by Country for Australia, Japan, China, India, South Korea and Rest of Asia-Pacific in US$ Million

Exhibit 196. RNAi Design/Software – Asia-Pacific Market Shares (2012, 2018 & 2022) by Country for Australia, Japan, China, India, South Korea and Rest of Asia-Pacific

3.9.1.5 Rest of World RNAi Design/Software Market

Exhibit 197. RNAi Design/Software – Rest of World Market – Historic, Current, and Forecast (2010 - 2022) for Brazil, Israel, South Africa and Other Countries US$ Million

Exhibit 198. RNAi Design/Software – Rest of World Market Shares (2012, 2018 & 2022) for Brazil, Israel, South Africa and Other Countries US$ Million

3.9.1.(a) MiRNA Target Scan Market

3.9.1.(a).1 Global MiRNA Target Scan Market

Exhibit 199. MiRNA Target Scan - Global Market – Historic, Current, and Forecast (2010 - 2022) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million

Exhibit 200. MiRNA Target Scan - Global Market Shares (2012, 2018 & 2022) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World

3.9.1.(a).2 North American MiRNA Target Scan Market

Exhibit 201. MiRNA Target Scan – North American Market – Historic, Current, and Forecast (2010 - 2022) for United States and Canada in US$ Million

Exhibit 202. MiRNA Target Scan – North American Market Shares (2012, 2018 & 2022) for United States and Canada

3.9.1.(a).3 European MiRNA Target Scan Market

Exhibit 203. MiRNA Target Scan - European Market – Historic, Current, and Forecast (2010 - 2022) by Country for Germany, United Kingdom, Belgium, France, Russia and Rest of Europe in US$ Million

Exhibit 204. MiRNA Target Scan – European Market Shares (2012, 2018 & 2022) by Country for Germany, United Kingdom, Belgium, France, Russia and Rest of Europe

3.9.1.(a).4 Asia-Pacific MiRNA Target Scan Market

Exhibit 205. MiRNA Target Scan - Asia-Pacific Market – Historic, Current, and Forecast (2010 - 2022) by Country for Australia, Japan, China, India, South Korea and Rest of Asia-Pacific in US$ Million

Exhibit 206. MiRNA Target Scan – Asia-Pacific Market Shares (2012, 2018 & 2022) by Country for Australia, Japan, China, India, South Korea and Rest of Asia-Pacific

3.9.1.(a).5 Rest of World MiRNA Target Scan Market

Exhibit 207. MiRNA Target Scan – Rest of World Market – Historic, Current, and Forecast (2010 - 2022) for Brazil, Israel, South Africa and Other Countries US$ Million

Exhibit 208. MiRNA Target Scan – Rest of World Market Shares (2012, 2018 & 2022) for Brazil, Israel, South Africa and Other Countries US$ Million

3.9.1.(b) MiRNA Analysis Software Market

3.9.1.(b).1 Global MiRNA Analysis Software Market

Exhibit 209. MiRNA Analysis Software - Global Market – Historic, Current, and Forecast (2010 - 2022) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million

Exhibit 210. MiRNA Analysis Software - Global Market Shares (2012, 2018 & 2022) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World

3.9.1.(b).2 North American MiRNA Analysis Software Market

Exhibit 211. MiRNA Analysis Software – North American Market – Historic, Current, and Forecast (2010 - 2022) for United States and Canada in US$ Million

Exhibit 212. MiRNA Analysis Software – North American Market Shares (2012, 2018 & 2022) for  United States and Canada

3.9.1.(b).3 European MiRNA Analysis Software Market

Exhibit 213. MiRNA Analysis Software - European Market – Historic, Current, and Forecast (2010 - 2022) by Country for Germany, United Kingdom, Belgium, France, Russia and Rest of Europe in US$ Million

Exhibit 214. MiRNA Analysis Software – European Market Shares (2012, 2018 & 2022) by Country for Germany, United Kingdom, Belgium, France, Russia and Rest of Europe

3.9.1.(b).4 Asia-Pacific MiRNA Analysis Software Market

Exhibit 215. MiRNA Analysis Software - Asia-Pacific Market – Historic, Current, and Forecast (2010 - 2022) by Country for Australia, Japan, China, India, South Korea and Rest of Asia-Pacific in US$ Million

Exhibit 216. MiRNA Analysis Software – Asia-Pacific Market Shares (2012, 2018 & 2022) by Country for Australia, Japan, China, India, South Korea and Rest of Asia-Pacific

3.9.1.(b).5 Rest of World MiRNA Analysis Software Market

Exhibit 217. MiRNA Analysis Software – Rest of World Market – Historic, Current, and Forecast (2010 - 2022) for Brazil, Israel, South Africa and Other Countries US$ Million

Exhibit 218. MiRNA Analysis Software – Rest of World Market Shares (2012, 2018 & 2022) for Brazil, Israel, South Africa and Other Countries US$ Million

3.9.1.(c) RNAi Design Algorithm Market

3.9.1.(c).1 Global RNAi Design Algorithm Market

Exhibit 219. RNAi Design Algorithm - Global Market – Historic, Current, and Forecast (2010 - 2022) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million

Exhibit 220. RNAi Design Algorithm - Global Market Shares (2012, 2018 & 2022) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World

3.9.1.(c).2 North American RNAi Design Algorithm Market

Exhibit 221. RNAi Design Algorithm – North American Market – Historic, Current, and Forecast (2010 - 2022) for United States and Canada in US$ Million

Exhibit 222. RNAi Design Algorithm – North American Market Shares (2012, 2018 & 2022) for United States and Canada

3.9.1.(c).3 European RNAi Design Algorithm Market

Exhibit 223. RNAi Design Algorithm - European Market – Historic, Current, and Forecast (2010 - 2022) by Country for Germany, United Kingdom, Belgium, France, Russia and Rest of Europe in US$ Million

Exhibit 224. RNAi Design Algorithm – European Market Shares (2012, 2018 & 2022) by Country for Germany, United Kingdom, Belgium, France, Russia and Rest of Europe

3.9.1.(c).4 Asia-Pacific RNAi Design Algorithm Market

Exhibit 225. RNAi Design Algorithm - Asia-Pacific Market – Historic, Current, and Forecast (2010 - 2022) by Country for Australia, Japan, China, India, South Korea and Rest of Asia-Pacific in US$ Million

Exhibit 226. RNAi Design Algorithm – Asia-Pacific Market Shares (2012, 2018 & 2022) by Country for Australia, Japan, China, India, South Korea and Rest of Asia-Pacific

3.9.1.(c).5 Rest of World RNAi Design Algorithm Market

Exhibit 227. RNAi Design Algorithm – Rest of World Market – Historic, Current, and Forecast (2010 - 2022) for Brazil, Israel, South Africa and Other Countries US$ Million

Exhibit 228. RNAi Design Algorithm – Rest of World Market Shares (2012, 2018 & 2022) for Brazil, Israel, South Africa and Other Countries US$ Million

3.9.1.(d) Other RNAi Design /Softwares

3.9.1.(d).1 Global Market for Other RNAi Design /Softwares

Exhibit 229. Other RNAi Design /Softwares- Global Market – Historic, Current, and Forecast (2010 - 2022) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million

Exhibit 230. Other RNAi Design /Softwares - Global Market Shares (2012, 2018 & 2022) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World

3.9.1.(d).2 North American Market for Other RNAi Design /Softwares

Exhibit 231. Other RNAi Design /Softwares – North American Market – Historic, Current, and Forecast (2010 - 2022) for United States and Canada in US$ Million

Exhibit 232. Other RNAi Design /Softwares – North American Market Shares (2012, 2018 & 2022) for United States and Canada

3.9.1.(d).3 European Market for Other RNAi Design /Softwares

Exhibit 233. Other RNAi Design /Softwares - European Market – Historic, Current, and Forecast (2010 - 2022) by Country for Germany, United Kingdom, Belgium, France, Russia and Rest of Europe in US$ Million

Exhibit 234. Other RNAi Design /Softwares – European Market Shares (2012, 2018 & 2022) by Country for Germany, United Kingdom, Belgium, France, Russia and Rest of Europe

3.9.1.(d).4 Asia-Pacific Market for Other RNAi Design /Softwares

Exhibit 235. Other RNAi Design /Softwares - Asia-Pacific Market – Historic, Current, and Forecast (2010 - 2022) by Country for Australia, Japan, China, India, South Korea and Rest of Asia-Pacific in US$ Million

Exhibit 236. Other RNAi Design /Softwares – Asia-Pacific Market Shares (2012, 2018 & 2022) by Country for Australia, Japan, China, India, South Korea and Rest of Asia-Pacific

3.9.1.(d).5 Rest of World Market for Other RNAi Design /Softwares

Exhibit 237. Other RNAi Design /Softwares – Rest of World Market – Historic, Current, and Forecast (2010 - 2022) for Brazil, Israel, South Africa and Other Countries US$ Million

Exhibit 238. Other RNAi Design /Softwares – Rest of World Market Shares (2012, 2018 & 2022) for Brazil, Israel, South Africa and Other Countries US$ Million

3.9.2 RNAi Synthesis

Exhibit 239. RNAi Synthesis Tools/Products - Global Market – Historic, Current, and Forecast (2010 - 2022) by Type for Expression Vector, Chemical, MiRNA Isolation, Dicer/RNAseIII, In Vitro and Other

Exhibit 240. RNAi Synthesis Tools/Products - Global Market Shares (2012, 2018 & 2022) by Type for Expression Vector, Chemical, MiRNA Isolation, Dicer/RNAseIII, In Vitro and Other

3.9.2.1 Global RNAi Synthesis Market

Exhibit 241. RNAi Synthesis - Global Market – Historic, Current, and Forecast (2010 - 2022) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million

Exhibit 242. RNAi Synthesis - Global Market Shares (2012, 2018 & 2022) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World

3.9.2.2 North American RNAi Synthesis Market

Exhibit 243. RNAi Synthesis – North American Market – Historic, Current, and Forecast (2010 - 2022) for United States and Canada in US$ Million

Exhibit 244. RNAi Synthesis – North American Market Shares (2012, 2018 & 2022) for United States and Canada

3.9.2.3 European RNAi Synthesis Market

Exhibit 245. RNAi Synthesis - European Market – Historic, Current, and Forecast (2010 - 2022) by Country for Germany, United Kingdom, Belgium, France, Russia and Rest of Europe in US$ Million

Exhibit 246. RNAi Synthesis – European Market Shares (2012, 2018 & 2022) by Country for Germany, United Kingdom, Belgium, France, Russia and Rest of Europe

3.9.2.4 Asia-Pacific RNAi Synthesis Market

Exhibit 247. RNAi Synthesis - Asia-Pacific Market – Historic, Current, and Forecast (2010 - 2022) by Country for Australia, Japan, China, India, South Korea and Rest of Asia-Pacific in US$ Million

Exhibit 248. RNAi Synthesis – Asia-Pacific Market Shares (2012, 2018 & 2022) by Country for Australia, Japan, China, India, South Korea and Rest of Asia-Pacific

3.9.2.5 Rest of World RNAi Synthesis Market

Exhibit 249. RNAi Synthesis – Rest of World Market – Historic, Current, and Forecast (2010 - 2022) for Brazil, Israel, South Africa and Other Countries US$ Million

Exhibit 250. RNAi Synthesis – Rest of World Market Shares (2012, 2018 & 2022) for Brazil, Israel,  South Africa and Other Countries US$ Million

3.9.2.(a) RNAi Synthesis Expression Vector Tools

3.9.2.(a).1 Global RNAi Synthesis Expression Vector Tools Market

Exhibit 251. RNAi Synthesis Expression Vector Tools - Global Market – Historic, Current, and Forecast (2010 - 2022) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million

Exhibit 252. RNAi Synthesis Expression Vector Tools - Global Market Shares (2012, 2018 & 2022) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World

3.9.2.(a).2 North American RNAi Synthesis Expression Vector Tools Market

Exhibit 253. RNAi Synthesis Expression Vector Tools – North American Market – Historic, Current, and Forecast (2010 - 2022) for United States and Canada in US$ Million

Exhibit 254. RNAi Synthesis Expression Vector Tools – North American Market Shares (2012, 2018 & 2022) for United States and Canada

3.9.2.(a).3 European RNAi Synthesis Expression Vector Tools Market

Exhibit 255. RNAi Synthesis Expression Vector Tools - European Market – Historic, Current, and Forecast (2010 - 2022) by Country for Germany, United Kingdom, Belgium, France, Russia and Rest of Europe in US$ Million

Exhibit 256. RNAi Synthesis Expression Vector Tools – European Market Shares (2012, 2018 & 2022) by Country for Germany, United Kingdom, Belgium, France, Russia and Rest of Europe

3.9.2.(a).4 Asia-Pacific RNAi Synthesis Expression Vector Tools Market

Exhibit 257. RNAi Synthesis Expression Vector Tools - Asia-Pacific Market – Historic, Current, and Forecast (2010 - 2022) by Country for Australia, Japan, China, India, South Korea and Rest of Asia-Pacific in US$ Million

Exhibit 258. RNAi Synthesis Expression Vector Tools – Asia-Pacific Market Shares (2012, 2018 & 2022) by Country for Australia, Japan, China, India, South Korea and Rest of Asia-Pacific

3.9.2.(a).5 Rest of World RNAi Synthesis Expression Vector Tools Market

Exhibit 259. RNAi Synthesis Expression Vector Tools – Rest of World Market – Historic, Current, and Forecast (2010 - 2022) for Brazil, Israel, South Africa and Other Countries US$ Million

Exhibit 260. RNAi Synthesis Expression Vector Tools – Rest of World Market Shares (2012, 2018 & 2022) for Brazil, Israel, South Africa and Other Countries

3.9.2.(b) RNAi Synthesis Chemicals

3.9.2.(b).1 Global RNAi Synthesis Chemicals Market

Exhibit 261. RNAi Synthesis Chemicals - Global Market – Historic, Current, and Forecast (2010 - 2022) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million

Exhibit 262. RNAi Synthesis Chemicals - Global Market Shares (2012, 2018 & 2022) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World

3.9.2.(b).2 North American RNAi Synthesis Chemicals Market

Exhibit 263. RNAi Synthesis Chemicals Market – North American Market – Historic, Current, and Forecast (2010 - 2022) for United States and Canada in US$ Million

Exhibit 264. RNAi Synthesis Chemicals Market – North American Market Shares (2012, 2018 & 2022) for United States and Canada

3.9.2.(b).3 European RNAi Synthesis Chemicals Market

Exhibit 265. RNAi Synthesis Chemicals - European Market – Historic, Current, and Forecast (2010 - 2022) by Country for Germany, United Kingdom, Belgium, France, Russia and Rest of Europe in US$ Million

Exhibit 266. RNAi Synthesis Chemicals – European Market Shares (2012, 2018 & 2022) by Country for Germany, United Kingdom, Belgium, France, Russia and Rest of Europe

3.9.2.(b).4 Asia-Pacific RNAi Synthesis Chemicals Market

Exhibit 267. RNAi Synthesis Chemicals - Asia-Pacific Market – Historic, Current, and Forecast (2010 - 2022) by Country for Australia, Japa

Savory Baked Goods (Savory and Deli Foods) Market in Venezuela - Outlook to 2020: Market Size, Growth and Forecast Analytics

Savoury Baked Goods - includes all Croque Monsieurs (grilled ham and cheese sandwich), Flans (baked dish consisting of an open-topped pastry case with a savoury or sweet filling), Quiches (pastry

USD 750View Report

Savory Baked Goods (Savory and Deli Foods) Market in the United States - Outlook to 2020: Market Size, Growth and Forecast Analytics

Savoury Baked Goods - includes all Croque Monsieurs (grilled ham and cheese sandwich), Flans (baked dish consisting of an open-topped pastry case with a savoury or sweet filling), Quiches (pastry

USD 750View Report

Savory Baked Goods (Savory and Deli Foods) Market in the United Kingdom - Outlook to 2020: Market Size, Growth and Forecast Analytics

Savoury Baked Goods - includes all Croque Monsieurs (grilled ham and cheese sandwich), Flans (baked dish consisting of an open-topped pastry case with a savoury or sweet filling), Quiches (pastry

USD 750View Report

Savory Baked Goods (Savory and Deli Foods) Market in Venezuela - Outlook to 2020: Market Size, Growth and Forecast Analytics

Savoury Baked Goods - includes all Croque Monsieurs (grilled ham and cheese sandwich), Flans (baked dish consisting of an open-topped pastry case with a savoury or sweet filling), Quiches (pastry

USD 750View Report

Savory Baked Goods (Savory and Deli Foods) Market in the United States - Outlook to 2020: Market Size, Growth and Forecast Analytics

Savoury Baked Goods - includes all Croque Monsieurs (grilled ham and cheese sandwich), Flans (baked dish consisting of an open-topped pastry case with a savoury or sweet filling), Quiches (pastry

USD 750View Report

Savory Baked Goods (Savory and Deli Foods) Market in the United Kingdom - Outlook to 2020: Market Size, Growth and Forecast Analytics

Savoury Baked Goods - includes all Croque Monsieurs (grilled ham and cheese sandwich), Flans (baked dish consisting of an open-topped pastry case with a savoury or sweet filling), Quiches (pastry

USD 750View Report

Fill The Form For Sample Request
Name*
Email*
Mobile No.*
LandLine No.
If you want to purchase particular section from this report then kindly contact us at contact@aarkstore.com.

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

Discount on PDF and Enterprise Wide Licence reports
  • PDF    $ 3600
  • Global Licence    $ 6900
$ 3600

Reports Details

Published Date : Dec 2015
No. of Pages :1147
Country :Global
Category :Healthcare
Publisher :RI Technologies
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

payment